Eudesmane Sesquiterpenoids from Dregea Volubilis Suppress Kidney Stones via Akt Signalling to Inhibit Oxalate Biosynthesis in Drosophila
Journal of Natural Products · 23.10.2026 · 89 (10) · 2887-2896
DOI: 10.1021/acs.jnatprod.6c00830 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Natural Products, online erschienen am 14.10.2026. Verfasst von Jinna Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry and Natural Medicine Chemistry, College of Pharmacy, Harbin Medical University, Baojian Road 157, Nangang District,…. Hauptthemen laut MEDLINE: Sesquiterpenes, Proto-Oncogene Proteins c-akt, Kidney Calculi, Oxalates. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Traditional Chinese Medicine Research Project of Heilongjiang Provincial Administration of Traditional Chinese Medicine, The Graduate Research and Practical Innovation Project of Harbin Medical University.
Abstract (Originalsprache)
Dregea volubilis has long been used in traditional medicine for the treatment of urolithiasis, yet its bioactive constituents and molecular mechanisms remain largely undefined. Here, molecular networking-guided UPLC-ESI-MS/MS analysis enabled the isolation of ten sesquiterpenoids, including eight previously undescribed compounds (compounds 1∼4, 6∼9). Among them, dregeaterpene A (1) exhibited potent anti-urolithic activity in Drosophila, surpassing the therapeutic efficacy of potassium citrate. Mechanistically, dregeaterpene A suppressed endogenous oxalate biosynthesis by restoring oxalate-impaired Akt phosphorylation, leading to the downregulation of Daao1 and Daao2, and the upregulation of Agxt. Consequently, oxalate accumulation and calcium oxalate stone formation were markedly reduced. Collectively, these findings identify eudesmane sesquiterpenoids from D. volubilis as bioactive anti-urolithic agents and establish Akt-dependent regulation of oxalate metabolism as their underlying mechanism of action, highlighting dregeaterpene A as a promising lead compound for the development of therapeutics against calcium oxalate urolithiasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry and Natural Medicine Chemistry, College of Pharmacy, Harbin Medical University, Baojian Road 157, Nangang District, Harbin150081, P. R. China.
- Department of Biopharmaceutical Sciences, College of Pharmacy, Harbin Medical University, Harbin150081, China.
- Xishuangbanna Dai Medicine Research Institute Co. Ltd, Jinghong666100, Yunnan, P. R. China.
ORCID-Profile: Libo Wang
Förderung
- Traditional Chinese Medicine Research Project of Heilongjiang Provincial Administration of Traditional Chinese Medicine
- The Graduate Research and Practical Innovation Project of Harbin Medical University
Zitieren
APA
Zhao, J., Guo, F., Wang, J., Wan, L., Zhang, L., Ding, Y., Chen, J., Li, B., Wang, L., Cong, B., & Wang, J. (2026). Eudesmane Sesquiterpenoids from Dregea Volubilis Suppress Kidney Stones via Akt Signalling to Inhibit Oxalate Biosynthesis in Drosophila. Journal of Natural Products, 89(10), 2887-2896. https://doi.org/10.1021/acs.jnatprod.6c00830
Vancouver
Zhao J, Guo F, Wang J, Wan L, Zhang L, Ding Y, et al. Eudesmane Sesquiterpenoids from Dregea Volubilis Suppress Kidney Stones via Akt Signalling to Inhibit Oxalate Biosynthesis in Drosophila. Journal of Natural Products. 2026;89(10):2887-2896. doi:10.1021/acs.jnatprod.6c00830
BibTeX
@article{Zhao2026,
author = {Zhao, Jinna and Guo, Faxiang and Wang, Jiahuan and Wan, Lvyou and Zhang, Lei and Ding, Yanjun and Chen, Jiahao and Li, Bo and Wang, Libo and Cong, Bojie and Wang, Jinhui},
title = {Eudesmane Sesquiterpenoids from Dregea Volubilis Suppress Kidney Stones via Akt Signalling to Inhibit Oxalate Biosynthesis in Drosophila},
journal = {Journal of Natural Products},
year = {2026},
volume = {89},
number = {10},
pages = {2887--2896},
doi = {10.1021/acs.jnatprod.6c00830}
}
EUVIMED